Closed system solutions for cell and gene therapy manufacturing

Wednesday 08:00 PST / 11:00 EST / 16:00 GMT / 17:00 CET

Sponsor

Closed system solutions for cell and gene therapy manufacturing

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast ye tinteractive format.

Cell therapies offer a promising approach to treat severe and rare diseases. However, sustained manufacturing of cell therapy products is at risk due to the high costs associated with manufacturing variability and safety assessments. One significant risk in the manufacturing process is contamination of product, which can contribute to millions of dollars in added cost. In this webinar, we will address how integrating closed system approaches during process development or manufacturing can mitigate contamination risk and associated costs.

This webinar will introduce viewers to Corning’s closed system solutions, with attention to the following topics:

Assembly and customization of closed systems
Closed system process considerations and flexibility in design
Scaling up and out using closed systems

Attend this webinar to learn more about:

Benefits of closed systems
Assessing risk of contamination
Key considerations for closed system design

Anette Funfak

Field Application Scientist Manager at Corning

Anette received her PhD in Natural Sciences from the Technical University Ilmenau, Germany in 2010, after studying bioprocess engineering at the Applied University, Jena, Germany. Since, she has worked for several prestigious research laboratories and industry in Paris, France with a focus on providing innovative technologies and products for 3D cell culture. Anette joined Corning in 2020 as Field Application Scientist (FAS), focusing on the drug discovery and bioprocess portfolio. She has led the Corning Field Application Scientist team in Europe since 2023, providing scientific and technical support for Corning’s bioprocess product portfolio.